Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oral microbiota is a complex ecological community comprising hundreds of species of bacteria, fungi, viruses, and archaea that inhabit the human oral cavity (Dewhirst et al., 2010). These microorganisms typically exist in a symbiotic relationship with the host, forming structured biofilms on tooth surfaces and mucosal tissues that contribute to immune maturation and prevent the colonization of exogenous pathogens (Kilian et al., 2016). However, environmental changes or poor hygiene can lead to dysbiosis, where pathogenic species such as Streptococcus mutans (associated with dental caries) or Porphyromonas gingivalis (associated with periodontitis) become dominant. These pathogens employ various virulence factors to cause tissue destruction and chronic inflammation, which are increasingly linked to systemic diseases like cardiovascular disorders and diabetes (Hajishengallis, 2015). Therapeutic management involves the use of mechanical debridement and antimicrobial agents, such as chlorhexidine or antibiotics, to reduce the pathogen load and restore a healthy microbial balance.
Antimicrobial agents target various bacterial processes: beta-lactams (e.g., amoxicillin) inhibit cell wall synthesis; tetracyclines (e.g., doxycycline) inhibit protein synthesis; nitroimidazoles (e.g., metronidazole) disrupt DNA. Fluoride inhibits bacterial glycolysis and promotes enamel remineralization (Kilian et al., 2016).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral microbiota and oral pathogens.